FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

126109000: Levonorgestrel (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
12082010 Levonorgestrel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730029013 Levonorgestrel (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
58331000195116 levonorgestrel it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
820681000172116 lévonorgestrel fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
73421000195119 Levonorgestrel de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levonorgestrel Is a Norgestrel false Inferred relationship Some
Levonorgestrel This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progestational hormone false Inferred relationship Some
Levonorgestrel Is a Synthetic progestogen (substance) true Inferred relationship Some
Levonorgestrel Is a Norsteroid true Inferred relationship Some
Levonorgestrel This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Gonadal hormone false Inferred relationship Some
Levonorgestrel Is a Steroid hormone true Inferred relationship Some
Levonorgestrel Is a Gonadal hormone false Inferred relationship Some
Levonorgestrel This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progesterone receptor agonist (disposition) true Inferred relationship Some
Levonorgestrel Is a Estrane true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Levonorgestrel-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levonorgestrel Inferred relationship Some 1
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levonorgestrel Inferred relationship Some 2
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levonorgestrel Inferred relationship Some 2
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levonorgestrel Inferred relationship Some 2
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levonorgestrel Inferred relationship Some 2
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levonorgestrel Inferred relationship Some 2
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levonorgestrel Inferred relationship Some 2
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levonorgestrel Inferred relationship Some 2
Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levonorgestrel Inferred relationship Some 2
Levonorgestrel 19.5 mg prolonged-release intrauterine drug delivery system The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levonorgestrel Inferred relationship Some 1
Levonorgestrel 19.5 mg prolonged-release intrauterine drug delivery system This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levonorgestrel Inferred relationship Some 1
Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levonorgestrel Inferred relationship Some 1
Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levonorgestrel Inferred relationship Some 1

Start Page 2 of 2


This concept is not in any reference sets

Back to Start